HEUKING advises OSYPKA on strategic partnership with Armira

A HEUKING team led by M&A lawyers Boris Dürr and Marcel Greubel advised the medical technology company OSYPKA AG and its shareholders on a strategic partnership with the financial investor Armira.

OSYPKA AG is a globally recognized provider and partner for innovative medical technology. The company offers advanced products such as electrodes and catheters for interventional and pediatric cardiology as well as cardiac surgery. In addition, OSYPKA provides technically and qualitatively demanding turnkey CDMO solutions to global contract partners, particularly in the field of electrically active implants and neurostimulation. Since its founding in 1977 by Prof. Dr. Peter Osypka, the company has stood for technical excellence and the improvement of the quality of life and care of patients worldwide.

Armira, based in Munich, is a leading investment holding company specializing in direct equity investments in medium-sized, profitable family businesses and ambitious growth companies in the DACH region, Northern Italy and beyond. Armira is backed by an exclusive investor base of families, entrepreneurs and entrepreneurial capital, seeking trustworthy partnerships with a long-term horizon.

Counsel to OSYPKA AG
HEUKING:
Boris Dürr (Lead, M&A), Munich,
Wolfram Meven (Foreign Trade Law) Düsseldorf,
Dr. Reinhard Siegert (Antitrust) Munich,
Astrid Wellhöner, LL.M. Eur. (Labour law),
Marcel Greubel (M&A),
Dr. Martin Ströhmann, LL.M. (Chicago) (Compliance),
Peter Michael Schäffler (Tax),
Dr. Ruth Jungkind (Antitrust),
Catarina Seemann, LL.M. (Medical Law) all Munich,
Astrid Luedtke (IP Media), Düsseldorf,
Sebastian Pollmeier,
Felix Noack (all M&A), both Munich